NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. - Sloan AE; Winter K; Gilbert MR; Aldape K; Choi S; Wen PY; Butowski N; Iwamoto FM; Raval RR; Voloschin AD; Kamiya-Matsuoka C; Won M; et al. (Neuro-oncology, 2024)